Lupin, Merck Serono partner to bring meds to emerging markets
MUMBAI — Lupin has entered into a long-term partnership with Merck Serono for the implementation of the company's general medicines portfolio expansion initiative in emerging markets, helping to fulfill local needs for affordable medications. The agreement could add up to 20 new products to the current portfolio, with the first launches expected to occur in 2016.
The partnership will cover major markets like Brazil, Mexico and Indonesia, among other emerging markets, and will focus on cardiovascular and diabetes diseases.
“The agreement with Lupin is an exciting new approach for Merck Serono to address local health needs in fast‐growing regions with constantly increasing demand for high quality medicines from trusted companies like Merck Serono and Lupin,” said Elcin Ergun, head of global commercial at Merck Serono. “The collaboration will significantly strengthen our portfolio and Merck Serono’s position as one of the major players in emerging markets, aiming to provide patients in these regions with better access to health.”
Lupin will develop products, provide dossiers and supply finished products to Merck Serono. Merck Serono will be
the marketing authorization holder for the products, and will use its commercial and medical teams to bring these new medicines to customers. Financial terms of the transaction were not released.
BelVita offers up free swag in new campaign
NEW YORK — BelVita Soft Baked Breakfast Biscuits announced the launch of its #MorningWin Swag Shop. From Sept. 15 to 19, belVita fans can log on to Morning Win.com from 9 a.m. to 1 p.m. for the opportunity to earn such items as yoga mats and coffee mugs. New items will be showcased every 30 minutes each day.
For a chance to win an item, consumers must make sure to follow the company on Twitter (@belVita) and tweet #MorningWin and that prizes' corresponding hashtag, which will appear along with the item on MorningWin.com. The brand also encourages users to include a description of a personal "Morning Win" in their tweets.
Each piece of swag will be accompanied by a box of belVita Soft Baked Breakfast Biscuits. For the official contest rules, visit MorningWin.com.
FDA approves AstraZeneca’s Movantik
SILVER SPRING — The Food and Drug Administration on Tuesday announced approval for Movantik (naloxegol), a treatment for opioid-induced constipation in adults. Opioids are used for the treatment and management of pain, but a common side effect associated with such drugs is that they reduce the gastrointestinal tract's motility, the agency said, making bowel movements difficult.
“Supportive care products such as Movantik can lessen the constipating side effects of opioids,” said Julie Beitz, M.D., director of the Office of Drug Evaluation III in the FDA’s Center for Drug Evaluation and Research.
Movantik is distributed by AstraZeneca.
Loading Post Please Wait...